T2 BIOSYSTEMS INC's ticker is TTOO and the CUSIP is 89853L104. A total of 45 filers reported holding T2 BIOSYSTEMS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $0 | – | 250 | +150.0% | 0.00% | – |
Q4 2020 | $0 | – | 100 | 0.0% | 0.00% | – |
Q3 2020 | $0 | – | 100 | 0.0% | 0.00% | – |
Q2 2020 | $0 | – | 100 | 0.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 100 | -99.8% | 0.00% | – |
Q4 2019 | $70,000 | -53.3% | 60,100 | 0.0% | 0.00% | – |
Q3 2019 | $150,000 | +48.5% | 60,100 | -0.1% | 0.00% | – |
Q2 2019 | $101,000 | -42.6% | 60,138 | -10.0% | 0.00% | – |
Q1 2019 | $176,000 | +32.3% | 66,850 | +50.7% | 0.00% | – |
Q4 2018 | $133,000 | +150.9% | 44,350 | +527.0% | 0.00% | – |
Q3 2018 | $53,000 | +32.5% | 7,073 | +36.3% | 0.00% | – |
Q2 2018 | $40,000 | +14.3% | 5,189 | -3.9% | 0.00% | – |
Q1 2018 | $35,000 | – | 5,400 | +33650.0% | 0.00% | – |
Q4 2017 | $0 | – | 16 | +433.3% | 0.00% | – |
Q3 2017 | $0 | -100.0% | 3 | -99.5% | 0.00% | – |
Q1 2017 | $3,000 | -40.0% | 565 | -44.4% | 0.00% | – |
Q4 2016 | $5,000 | – | 1,017 | +2805.7% | 0.00% | – |
Q4 2015 | $0 | -100.0% | 35 | -89.3% | 0.00% | – |
Q3 2015 | $3,000 | -62.5% | 326 | -36.1% | 0.00% | – |
Q2 2015 | $8,000 | – | 510 | +5566.7% | 0.00% | – |
Q4 2014 | $0 | – | 9 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GAGNON SECURITIES LLC | 760,610 | $393,000 | 0.06% |
Virtu Financial LLC | 272,090 | $140,000 | 0.01% |
Founders Capital Management | 40,000 | $21,000 | 0.01% |
Continuum Advisory, LLC | 50,000 | $26,000 | 0.01% |
LEVIN CAPITAL STRATEGIES, L.P. | 113,451 | $59,000 | 0.01% |
McAdam, LLC | 113,201 | $58,000 | 0.01% |
Patriot Financial Group Insurance Agency, LLC | 50,600 | $26,000 | 0.00% |
Navis Wealth Advisors, LLC | 10,000 | $5,000 | 0.00% |
BRAVE ASSET MANAGEMENT INC | 26,400 | $14,000 | 0.00% |
COURIER CAPITAL LLC | 81,500 | $42,000 | 0.00% |